| Literature DB >> 34178721 |
H Melis Soylu1, Pascale Chevallier2, Francesco Copes2, Federica Ponti2,3, Gabriele Candiani3, Fatma Yurt1,4, Diego Mantovani2.
Abstract
Introduction: The use of spinal implants for the treatment of back disorders is largely affected by the insurgence of infections at the implantation site. Antibacterial coatings have been proposed as a viable solution to limit such infections. However, despite being effective at short-term, conventional coatings lack the ability to prevent infections at medium and long-term. Hydrogel-based drug delivery systems may represent a solution controlling the release of the loaded antibacterial agents while improving cell integration. Agarose, in particular, is a biocompatible natural polysaccharide known to improve cell growth and already used in drug delivery system formulations. In this study, an agarose hydrogel-based coating has been developed for the controlled release of gentamicin (GS).Entities:
Keywords: Ti6Al4V; agarose; antibacterial coatings; gentamicin; spinal implants
Year: 2021 PMID: 34178721 PMCID: PMC8224171 DOI: 10.3389/fcimb.2021.678081
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Advantages and disadvantages of some coatings on Ti and Ti alloys, reported in the literature.
| Coating composition | Advantages | Disadvantages | Ref. |
|---|---|---|---|
| Chitosan | - Drug release effective against | - 95% of vancomycin released after 5 min | ( |
| Vancomycin release | - 65% of the drug released after 1 min - Total drug release 2.4 mg | - Multistep process (aminosilane, glutaraldehyde, chitosan grafting then chitosan/vancomycine coating) - Multilayer, thick and inhomogeneous coating | |
| Calcium alginate gelatin | - Excellent antibacterial activity against | - Antibacterial effect tests done after 18 hours | ( |
| Gentamicin release | - During the first 8 h, 61.7% gentamicin released, then the release lasts for 10 days | - Multistep process | |
| Polydopamine, hydroxyapatite (HAp), Ag NPs* and chitosan (CS) | - HAp/Ag/CS coating inhibited bacterial growth against | - No indication of the antibacterial effect time | ( |
|
| - No cytotoxicity | - Not reliable to a coating process | |
| HAp and AgNO3
| - After 20 h, silver ions significantly improved the antibacterial activity on | - Antibacterial activity effect for 1 day | ( |
| Dopamine, chitosan and immobilized RGD | - Adhesion of bacteria, | - Bacteria adhesion tests done for only 4 h | ( |
| RGD peptide release | - Increase in osteoblast cell attachment and proliferation | - Unfriendly chemicals (HF, glutaraldehyde, etc.) | |
| Thin films of either poly (2-hydroxyethyl methacrylate) or a copolymer based on poly (ethylene–glycol diacrylate) and acrylic acid | - Biocompatible | - Short term release kinetics | ( |
*NPs, nanoparticles; **MRSA0, methicillin resistant Staphylococcus aureus (MRSA); ***MIC, minimum inhibition concentration.
Different coating conditions of Ti6Al4V surfaces.
| Conditions | |
|---|---|
|
| Ti6Al4V-DOPA |
|
| Ti6Al4V -DOPA-Agr |
|
| Ti6Al4V -DOPA-Agr-GS |
|
| Ti6Al4V -DOPA-Agr-GS-TA |
|
| Ti6Al4V -DOPA-Agr-GS-TA-CaCl2 |
Average XPS atomic surface composition, surface roughness and contact angle values for crude Ti6Al4V, pretreated and DOPA grafted samples.
| Sample | Atomic Percentage % | Ra(µm) | CA (°) | |||
|---|---|---|---|---|---|---|
| C | O | N | Ti | |||
| Ti6Al4V | 27.4 ± 2.1 | 52.9 ± 1.3 | – | 12.2 ± 0.8 | 0.55 ± 0.09 | 28.7 ± 0.3 |
| Pretreated | 24.0 ± 1.6 | 55.5 ± 0.9 | – | 20.5 ± 0.8 | 0.58 ± 0.01 | 6.6 ± 0.7 |
| DOPA | 70.6 ± 0.8 | 21.2 ± 0.9 | 8.2 ± 0.9 | – | 0.59 ± 0.03 | 66.8 ± 2.6 |
Average XPS atomic composition of the different coatings.
| Sample | Atomic percentage | ||||
|---|---|---|---|---|---|
| % C | % O | % N | % Ca | % Cl | |
|
| 70.6 ± 0.8 | 21.2 ± 0.9 | 8.2 ± 0.9 | – | – |
|
| 62.3 ± 0.4 | 37.0 ± 0.2 | 0.7 ± 0.4 | – | – |
|
| 61.3 ± 1.0 | 38.4 ± 0.7 | 0.3 ± 0.5 | – | – |
|
| 63.9 ± 1.1 | 35.5 ± 1.6 | 0.6 ± 0.5 | – | – |
|
| 63.4 ± 0.7 | 34.1 ± 0.9 | – | 0.9 ± 0.4 | 1.6 ± 1.1 |
Figure 1XPS high resolution C1s spectra of agarose-based coating on Ti6Al4V surfaces: C2-Agr; C3-Agr/GS; C4-Agr/TA/GS, and C5-Agr/TA/GS/CaCl2.
Figure 2Contact angle measurements and water drop images on the sample’s surfaces.
Figure 3Topographic maps for Ti6Al4V-DOPA and the different agarose-based coatings.
Figure 4Gentamicin (GS) release concentrations from GS-loaded agarose-coated samples.
Figure 5Indirect Viability Assay. Saos-2 cells were treated with conditioned medium collected after 6 hours, 1, 3 and 7 days of incubation with the following conditions: C1, C2, C3, C4 and C5. Normal culture media was used as a control (Control). The graphic shows the relative viability ± SD for each condition.
Figure 6Inhibition zones of Ti6Al4V discs.
Figure 7Percentage of antibacterial activity of Ti6Al4V-coated samples (i.e., C2, C3, C4, C5) with respect to uncoated Ti6Al4V surfaces (i.e. C1) against S. aureus 24 hours after inoculation.